PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR (Q28240702)
Jump to navigation
Jump to search
scientific article (publication date: 15 April 2009)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR |
scientific article (publication date: 15 April 2009) |
Statements
PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR (English)
0 references
15 April 2009
0 references
69
0 references
3256-61
0 references
8
0 references